Clinical trial
Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
NCT00154726 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00154726 |
|---|---|
| Title | Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers |
| Official title | A Phase II Study of Weekly Paclitaxel(Taxol)and 24-Hour Infusion High-Dose 5-Fluorouracil and Leucovorin(HDFL)in the Treatment Locally Advanced and Recurrent/Metastatic Gastric Cancers |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Locally Advanced and Recurrent/Metastatic Gastric Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel-HDFL |
| Enrollment | 40 |
| Start date | Apr 1, 1997 |
| Completion | Aug 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 22, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: